These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 4888499)

  • 1. Retrospective leukocyte typing of unrelated human donor-recipient pairs in relation to skin allograft survival times. A study of 17 well defined specificities.
    Walford RL; Colombani J; Dausset J
    Transplantation; 1969 Mar; 7(3):188-93. PubMed ID: 4888499
    [No Abstract]   [Full Text] [Related]  

  • 2. Determination of histocompatibility antigens by leukocyte typing in outbred guinea pigs and effect of matching on skin graft survival.
    De Weck AL; Polak L; Sato W; Frey JR
    Transplant Proc; 1971 Mar; 3(1):192-4. PubMed ID: 4937887
    [No Abstract]   [Full Text] [Related]  

  • 3. Aortic valve allograft structural deterioration is associated with a subset of antibodies to human leukocyte antigens.
    Dignan R; O'Brien M; Hogan P; Thornton A; Fowler K; Byrne D; Stephens F; Harrocks S
    J Heart Valve Dis; 2003 May; 12(3):382-90; discussion 390-1. PubMed ID: 12803340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Tissue typing: current methods from critical viewpoint].
    Tilz GP; Heschl R; Schaffer D; Sailer S
    Wien Med Wochenschr; 1970 May; 120(22):404-8. PubMed ID: 4933019
    [No Abstract]   [Full Text] [Related]  

  • 5. Tissue typing and organ transplantation.
    Singal DP
    Can J Surg; 1972 Sep; 15(5):295-9. PubMed ID: 4116489
    [No Abstract]   [Full Text] [Related]  

  • 6. Studies of skin allograft survival and mixed lymphocyte culture reaction in Hl-A-genotyped families.
    Sasportes M; Lebrun A; Rapaport FT; Dausset J
    Transplant Proc; 1972 Jun; 4(2):209-18. PubMed ID: 4556065
    [No Abstract]   [Full Text] [Related]  

  • 7. Graft survival in unrelated donor--recipient pairs matched for MLC and HL-A.
    van Rood JJ; Koch CT; van Hooff JP; van Leeuwen A; van den Tweel JG; Frederiks E; Schippers HM; Hendriks G; van der Steen GJ
    Transplant Proc; 1973 Mar; 5(1):409-14. PubMed ID: 4266668
    [No Abstract]   [Full Text] [Related]  

  • 8. Histocompatibility testing. II. Identification of the genetic constitutions of prospective recipient and potential donor using the third party test.
    Elandt-Johnson RC
    Am J Hum Genet; 1968 May; 20(3):228-49 concl. PubMed ID: 4873637
    [No Abstract]   [Full Text] [Related]  

  • 9. Prolongation of mouse skin allograft survival by treatment with cytosine arabinoside in combination with F 1 hybrid lymphocytes.
    Amaku EO; May AG; Hall TC; Linke CA
    Transplantation; 1971 Oct; 12(4):249-52. PubMed ID: 4939817
    [No Abstract]   [Full Text] [Related]  

  • 10. Histocompatibility studies in haploidentical genetic combinations.
    Dausset J; Rapaport FT
    Transplant Proc; 1969 Mar; 1(1):649-58. PubMed ID: 4944282
    [No Abstract]   [Full Text] [Related]  

  • 11. TRANSPLANTATION TOLERANCE INDUCED IN ADULT MICE BY PROTEIN OVERLOADING OF DONORS.
    LIACOPOULOS P; GOODE JH
    Science; 1964 Dec; 146(3649):1305-7. PubMed ID: 14207456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Limitations of the nonimmune lymphocyte transfer test as a method of selecting donors for transplantation (a review of the literature)].
    Shereshkov SI
    Probl Gematol Pereliv Krovi; 1973 May; 18(5):47-52. PubMed ID: 4150019
    [No Abstract]   [Full Text] [Related]  

  • 13. Current status of tissue typing for allotransplantation.
    Fernbach DJ; Mittal KK
    Ann Allergy; 1970 Oct; 28(10):459-66. PubMed ID: 4939466
    [No Abstract]   [Full Text] [Related]  

  • 14. Is antibody essential for enhancement of skin allograft survival following preinjection of donor lymphocyte antigens?
    Lee CK; Reif AE; Deterling RA
    Transplantation; 1972 Mar; 13(3):339-43. PubMed ID: 4553736
    [No Abstract]   [Full Text] [Related]  

  • 15. Cell-mediated lympholysis studies in renal allograft recipients.
    Goulmy E; Persijn G; Blokland E; D'Amaro J; van Rood JJ
    Transplantation; 1981 Mar; 31(3):210-7. PubMed ID: 7015616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphocyte typing in allografted beagles.
    Mollen N; Cannon FD; Ferrebee JW; St John D
    Transplantation; 1968 Nov; 6(8):939-40. PubMed ID: 4880330
    [No Abstract]   [Full Text] [Related]  

  • 17. Prolongation of skin graft survival by donor treatment (donor enhancement).
    Barkin M; Hambly EJ; Dimitriu D
    Transplantation; 1972 Jan; 13(1):18-20. PubMed ID: 4550342
    [No Abstract]   [Full Text] [Related]  

  • 18. [The law of choice of an organ donor for transplantation].
    Dausset J
    Arch Mal Coeur Vaiss; 1969 Jun; 62(6):841-7. PubMed ID: 4997003
    [No Abstract]   [Full Text] [Related]  

  • 19. [The importance of subgroups A1-A2 and cross reactions A-B for the survival of skin allografts].
    Visetti M; Leigheb G; Scudeller G; Ceppellini R
    Minerva Dermatol; 1967 Dec; 42(12):563-9. PubMed ID: 4908971
    [No Abstract]   [Full Text] [Related]  

  • 20. Ranks of donor-recipient histocompatibility for human transplantation.
    Rapaport FT; Dausset J
    Science; 1970 Feb; 167(3922):1260-2. PubMed ID: 4904280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.